The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of lurbinectedin (PM1183) in Ewing sarcoma: Final results from a phase 2 study.
 
Vivek Subbiah
Consulting or Advisory Role - MedImmune
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; PharmaMar
 
Kamalesh Kumar Sankhala
No Relationships to Disclose
 
Ravin Ratan
No Relationships to Disclose
 
Enrique Sanz Garcia
No Relationships to Disclose
 
Valentina Boni
No Relationships to Disclose
 
Thierry Gil
No Relationships to Disclose
 
Victor Manuel Villalobos
Consulting or Advisory Role - Abbvie; Ignyta; Janssen; Lilly; Novartis
Travel, Accommodations, Expenses - Janssen; Lilly; Xencor
 
Sant P Chawla
No Relationships to Disclose
 
Pilar Lardelli
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Mariano Siguero
Employment - PharmaMar
Honoraria - PharmaMar
 
Carmen Maria Kahatt
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Arturo Soto-Matos
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Stefano Ferrari
No Relationships to Disclose